EisnerAmper Announces Software and Biotech Leadership Appointments
- Published
- Mar 26, 2024
- Share
EisnerAmper, a leading global business advisory firm, is pleased to announce new leadership appointments within its Technology and Life Sciences practices. Sector leaders are responsible for growth initiatives and team development within their verticals as well as collaborating on overall industry strategy.
Thomas H. Fagley: National Biotech Sector Leader
Tom is an Audit Partner with approximately 30 years in public accounting and private practice experience. He works with both public and private companies with a focus on the life sciences sector. Tom has extensive expertise providing solutions for organizations that specialize in biotechnology, pharmaceuticals, medical devices, contract research, and venture capital. Tom also provides interim chief financial officer services to private companies and SEC reporting services for public companies.
R. Brooks Malone III: National Software Sector Leader
With approximately 35 years of public accounting experience, Brooks Malone is a partner specializing in financial reporting, business consulting, and financial planning. He has significant experience helping high-growth and investor-backed technology companies and their founders and executives including software, SaaS, hardware, and related industries. Active in the entrepreneurial community, including Raleigh Founded and American Underground, Brooks has also written a tech leader column called “The Download” for GrepBeat since 2018.
“Tom and Brooks have vast and vital experience in their respective specialties, and our life sciences and technology clients and colleagues will benefit greatly from their leadership,” said John Pennett, EisnerAmper’s National Technology and Life Sciences Group Leader.
“Our capabilities have been greatly enhanced with the addition of colleagues from Hughes Pittman & Gupton, LLP (HPG) and, as HPG vets, Tom and Brooks bring new perspectives and experience to bear on our rapidly growing tech and life sciences industry groups. We’re excited for the future of these practices,” added Jay Weinstein, Vice Chair of Growth for EisnerAmper.
Have questions or comments? We'd like to hear from you.